Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学HLA-LOH, Checkpoint Resistance

Jesse Zaretsky

MD, PhD

🏢University of California, Los Angeles🌐USA

Assistant Professor of Medicine

18
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Jesse Zaretsky identified key mechanisms of acquired resistance to anti-PD-1 immunotherapy, including truncating mutations in B2M that abrogate MHC-I surface expression and loss-of-function mutations in JAK1/JAK2 that block IFN-gamma-mediated MHC upregulation. His landmark study in melanoma patients established the molecular framework for understanding how tumors evolve to escape checkpoint blockade through antigen presentation defects.

Share:

🧪Research Fields 研究领域

HLA loss of heterozygosity
checkpoint resistance mechanisms
JAK1/2 mutations
B2M truncation
acquired resistance immunotherapy

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Jesse Zaretsky 的研究动态

Follow Jesse Zaretsky's research updates

留下邮箱,当我们发布与 Jesse Zaretsky(University of California, Los Angeles)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment